Javascript must be enabled to continue!
Value of the acute asthma intensity research score (AAIRS) for asthma exacerbations in children
View through CrossRef
Background: Correct severity assessment of asthma exacerbations helps in appropriate management. The purpose of the study was to investigate the value of the Acute Asthma Intensity Research Score (AAIRS) in assessing the severity of asthma exacerbations in children. Methods: A cross-sectional descriptive study was conducted in 226 children aged 1-15 years admitted with asthma exacerbations from April 2018 to June 2020. Results: The majority of children were admitted with severe asthma exacerbations (44.2% in children aged 1-5 years and 85.5% in children aged 6-15 years). The prevalence of mild, moderate, and severe AAIRS were 31.0%, 56.6%, and 12.4%, respectively. In children 5 years and younger, AAIRS ≥ 9 had a sensitivity of
73.81% and a specificity of 83.02% in the classification of severe asthma exacerbations according to the guidelines of Vietnam Ministry of Health (AUC = 0.833) with Cohen’s kappa coefficient k = 0.17. In children aged 6-15 years, AAIRS ≥ 6 had a sensitivity of 89.29% and a specificity of 100% in the classification of severe asthma exacerbations according to the GINA guidelines (AUC = 0.951) with Cohen’s kappa coefficient k = 0.56. Conclusion: The AAIRS was not a substitute for current guidelines for assessing asthma exacerbation severity, especially in children aged 1-5 years.
Key words: asthma exacerbations, AAIRS, children
Hue University of Medicine and Pharmacy
Title: Value of the acute asthma intensity research score (AAIRS) for asthma exacerbations in children
Description:
Background: Correct severity assessment of asthma exacerbations helps in appropriate management.
The purpose of the study was to investigate the value of the Acute Asthma Intensity Research Score (AAIRS) in assessing the severity of asthma exacerbations in children.
Methods: A cross-sectional descriptive study was conducted in 226 children aged 1-15 years admitted with asthma exacerbations from April 2018 to June 2020.
Results: The majority of children were admitted with severe asthma exacerbations (44.
2% in children aged 1-5 years and 85.
5% in children aged 6-15 years).
The prevalence of mild, moderate, and severe AAIRS were 31.
0%, 56.
6%, and 12.
4%, respectively.
In children 5 years and younger, AAIRS ≥ 9 had a sensitivity of
73.
81% and a specificity of 83.
02% in the classification of severe asthma exacerbations according to the guidelines of Vietnam Ministry of Health (AUC = 0.
833) with Cohen’s kappa coefficient k = 0.
17.
In children aged 6-15 years, AAIRS ≥ 6 had a sensitivity of 89.
29% and a specificity of 100% in the classification of severe asthma exacerbations according to the GINA guidelines (AUC = 0.
951) with Cohen’s kappa coefficient k = 0.
56.
Conclusion: The AAIRS was not a substitute for current guidelines for assessing asthma exacerbation severity, especially in children aged 1-5 years.
Key words: asthma exacerbations, AAIRS, children.
Related Results
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
Biomarker profiles and immune cell populations in distinct asthma endotypes
Biomarker profiles and immune cell populations in distinct asthma endotypes
<p dir="ltr">Asthma affects 260 million individuals globally and imposes a substantial health burden. Its hallmarks include chronic airway inflammation, airway hyperresponsiv...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
The Impact of Adverse Childhood Experiences on Asthma Severity in US Adults
Background/objectives: The association between adverse childhood experiences (ACEs) and asthma severity among United States (US) adults with asthma has not been well documented. In...
Clinic and functional features of chronic obstructive pulmonary disease after virus-induced acute exacerbations.
Clinic and functional features of chronic obstructive pulmonary disease after virus-induced acute exacerbations.
Aim. To establish symptoms, lung function and to evaluate subsequent exacerbations of chronic obstructive pulmonary disease (COPD) during a year after virus-induced COPD exacerbati...
Hubungan Tingkat Pengetahuan Mengenai Asma dengan Tingkat Kontrol Asma
Hubungan Tingkat Pengetahuan Mengenai Asma dengan Tingkat Kontrol Asma
AbstrakKontrol gejala asma yang baik merupakan tujuan pengobatan bagi pasien asma. Pengobatan medikamentosa dan self management dibutuhkan untuk mencapai kontrol asma. Pengobatan m...
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
ASTHMA AND RESPIRATORY SYMPTOMS RELATED TO THE ENVIRONMENT
Asthma, a ubiquitous chronic respiratory ailment, stands as a formidable global health concern, affecting millions of individuals across the world. This widespread condition, marke...

